Amplitude Surgical SA
PAR:AMPLI
Intrinsic Value
Amplitude Surgical SAS engages in the manufacturing, marketing and design of orthopedic products. [ Read More ]
The intrinsic value of one
AMPLI
stock under the Base Case scenario is
3.17
EUR.
Compared to the current market price of 2.8 EUR,
Amplitude Surgical SA
is
Undervalued by 12%.
Amplitude Surgical SA's market capitalization is 134.5m EUR.
AMPLI stock price is 2.8 EUR.
AMPLI stock price (2.8 EUR) is 12% less than its Intrinsic Value (3.17 EUR).
AMPLI has upside potential of 52% compared to the average analyst price target.
Open Wall St Estimates
AMPLI's D/E (Debt to Equity) is equal to 1.05.
AMPLI's Revenue has been growing by 7% per year for the last 3 years.
AMPLI's Revenue has grown by an exceptional 23% over the past 12 months.
AMPLI has positive Operating Income for the last twelve months.
AMPLI's long-term assets (269m EUR) exceed its long-term liabilties (174m EUR).
AMPLI has positive Net Income for the last twelve months.
AMPLI has a very low three-year average ROE (Return on Equity): 3%. The company is not efficient at transforming stockholders' equity into net income.
AMPLI's ROE (Return on Equity) has significantly increased in the last 3 years from -31% to 59%.
AMPLI's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -5% to -55%, and is approaching profitability.
AMPLI has positive Net Debt. This means that the company has more debt (100m EUR) than cash and short-term investments (31m EUR).
AMPLI's short-term assets (93m EUR) exceed its short-term liabilties (43m EUR).
AMPLI's ROE (Return on Equity) for the past 12 months is very high and is equal to 59%.
AMPLI's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -55%.
AMPLI has positive Gross Profit for the last twelve months.
AMPLI has negative three-year average ROIC (Return on Invested Capital): -9%. The company is not efficient at using invested capital to generate operating income.
AMPLI has negative Free Cash Flow for the last twelve months.
AMPLI's Altman Z-Score is very low and is equal to 0.86.
Valuation Backtest
Amplitude Surgical SA
Run backtest to discover the historical profit from buying and selling
AMPLI
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Amplitude Surgical SA
Balance Sheet Decomposition
Amplitude Surgical SA
| Current Assets | 92.7m |
| Cash & Short-Term Investments | 31.3m |
| Receivables | 18.9m |
| Other Current Assets | 42.5m |
| Non-Current Assets | 175.9m |
| Long-Term Investments | 652k |
| PP&E | 41m |
| Intangibles | 128.8m |
| Other Non-Current Assets | 5.5m |
| Current Liabilities | 42.7m |
| Accounts Payable | 16.8m |
| Accrued Liabilities | 8.6m |
| Short-Term Debt | 1.1m |
| Other Current Liabilities | 16.3m |
| Non-Current Liabilities | 131.2m |
| Long-Term Debt | 98.8m |
| Other Non-Current Liabilities | 32.4m |
Earnings Waterfall
Amplitude Surgical SA
|
Revenue
|
104m
EUR
|
|
Cost of Revenue
|
-37.9m
EUR
|
|
Gross Profit
|
66.2m
EUR
|
|
Operating Expenses
|
-57.9m
EUR
|
|
Operating Income
|
8.3m
EUR
|
|
Other Expenses
|
34.9m
EUR
|
|
Net Income
|
43.2m
EUR
|
Free Cash Flow Analysis
Amplitude Surgical SA
AMPLI Profitability Score
Profitability Due Diligence
Amplitude Surgical SA's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Amplitude Surgical SA's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
AMPLI Solvency Score
Solvency Due Diligence
Amplitude Surgical SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Amplitude Surgical SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMPLI Price Targets Summary
Amplitude Surgical SA
According to Wall Street analysts, the average 1-year price target for
AMPLI
is 4.25 EUR
.
Shareholder Return
AMPLI Price
Amplitude Surgical SA
| Average Annual Return | 12.41% |
| Standard Deviation of Annual Returns | 32.38% |
| Max Drawdown | -60% |
| Market Capitalization | 134.5m EUR |
| Shares Outstanding | 48 020 800 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Amplitude Surgical SA
Country
Industry
Market Cap
Dividend Yield
Description
Amplitude Surgical SAS engages in the manufacturing, marketing and design of orthopedic products. The company is headquartered in Valence, Auvergne-Rhone-Alpes and currently employs 460 full-time employees. The company went IPO on 2015-06-26. The firm offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. The company operates through ofab Orthopedie, a strategic industrial subcontractor
Contact
IPO
Employees
Officers
The intrinsic value of one
AMPLI
stock under the Base Case scenario is
3.17
EUR.
Compared to the current market price of 2.8 EUR,
Amplitude Surgical SA
is
Undervalued by 12%.
You don't have any saved screeners yet
